blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3290053

EP3290053 - TOPICAL COMPOSITION COMPRISING OXYBUTYNIN FOR THE TREATMENT OF HYPERHIDROSIS [Right-click to bookmark this link]
Former [2018/10]EXTERNAL AGENT FOR TREATING HYPERHIDROSIS
[2020/45]
StatusNo opposition filed within time limit
Status updated on  24.12.2021
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  15.01.2021
FormerGrant of patent is intended
Status updated on  02.11.2020
FormerExamination is in progress
Status updated on  24.03.2020
FormerRequest for examination was made
Status updated on  02.02.2018
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Hisamitsu Pharmaceutical Co., Inc.
408, Tashirodaikan-machi
Tosu-shi, Saga 841-0017 / JP
[2018/10]
Inventor(s)01 / IMAMURA, Kana
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
02 / SHINODA, Tomohiro
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
03 / SOMEKAWA, Shingo
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
04 / MICHINAKA, Yasunari
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
 [2020/49]
Former [2018/10]01 / IMAMURA Kana
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
02 / SHINODA Tomohiro
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
03 / SOMEKAWA Shingo
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
04 / MICHINAKA Yasunari
c/o HISAMITSU PHARMACEUTICAL CO. INC.
1-25-11 Kannondai
Tsukuba-shi Ibaraki 305-0856 / JP
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2018/10]
Application number, filing date16786516.127.04.2016
[2018/10]
WO2016JP63188
Priority number, dateJP2015009294630.04.2015         Original published format: JP 2015092946
[2018/10]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016175240
Date:03.11.2016
Language:JA
[2016/44]
Type: A1 Application with search report 
No.:EP3290053
Date:07.03.2018
Language:EN
[2018/10]
Type: B1 Patent specification 
No.:EP3290053
Date:17.02.2021
Language:EN
[2021/07]
Search report(s)International search report - published on:JP03.11.2016
(Supplementary) European search report - dispatched on:EP07.12.2018
ClassificationIPC:A61K31/216, A61K9/00, A61K9/08, A61K47/04, A61K47/12, A61P43/00
[2019/02]
CPC:
A61K9/0014 (EP,US); A61K9/08 (EP,KR,US); A61K47/12 (EP,KR,US);
A61K31/216 (EP,KR,US); A61K9/06 (KR); A61P17/00 (US);
A61P43/00 (EP,US) (-)
Former IPC [2018/10]A61K45/00, A61K9/08, A61K31/216, A61K47/04, A61K47/12, A61P25/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:TOPISCHES PRÄPARAT ENTHALTEND OXYBUTYNIN ZUR BEHANDLUNG VON HYPERHIDROSE[2020/45]
English:TOPICAL COMPOSITION COMPRISING OXYBUTYNIN FOR THE TREATMENT OF HYPERHIDROSIS[2020/45]
French:PRÉPARATION TOPIQUE CONTENANT DE L'OXYBUTYNINE DESTINÉE AU TRAITEMENT DE L'HYPERHIDROSE[2020/45]
Former [2018/10]EXTERNES MITTEL ZUR BEHANDLUNG VON HYPERHIDROSE
Former [2018/10]EXTERNAL AGENT FOR TREATING HYPERHIDROSIS
Former [2018/10]AGENT EXTERNE POUR TRAITER L'HYPERHIDROSE
Entry into regional phase27.11.2017Translation filed 
27.11.2017National basic fee paid 
27.11.2017Search fee paid 
27.11.2017Designation fee(s) paid 
27.11.2017Examination fee paid 
Examination procedure27.11.2017Examination requested  [2018/10]
27.11.2017Date on which the examining division has become responsible
30.04.2019Amendment by applicant (claims and/or description)
27.03.2020Despatch of a communication from the examining division (Time limit: M04)
22.07.2020Reply to a communication from the examining division
03.11.2020Communication of intention to grant the patent
22.12.2020Fee for grant paid
22.12.2020Fee for publishing/printing paid
22.12.2020Receipt of the translation of the claim(s)
Opposition(s)18.11.2021No opposition filed within time limit [2022/04]
Fees paidRenewal fee
25.04.2018Renewal fee patent year 03
24.04.2019Renewal fee patent year 04
18.03.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.04.2016
AL17.02.2021
AT17.02.2021
CY17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
MK17.02.2021
MT17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
TR17.02.2021
IE27.04.2021
LU27.04.2021
BE30.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
[2024/41]
Former [2024/29]HU27.04.2016
AL17.02.2021
AT17.02.2021
CY17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
MK17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
TR17.02.2021
IE27.04.2021
LU27.04.2021
BE30.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2024/22]HU27.04.2016
AL17.02.2021
AT17.02.2021
CY17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
MK17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
IE27.04.2021
LU27.04.2021
BE30.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2023/30]HU27.04.2016
AL17.02.2021
AT17.02.2021
CY17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
IE27.04.2021
LU27.04.2021
BE30.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2023/29]HU27.04.2016
AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
IE27.04.2021
LU27.04.2021
BE30.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2022/34]AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
IE27.04.2021
LU27.04.2021
BE30.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2022/23]AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
IE27.04.2021
LU27.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2022/21]AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
IE27.04.2021
LU27.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2022/11]AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SI17.02.2021
SK17.02.2021
SM17.02.2021
LU27.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2022/10]AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SK17.02.2021
SM17.02.2021
LU27.04.2021
CH30.04.2021
LI30.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2022/07]AL17.02.2021
AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SK17.02.2021
SM17.02.2021
LU27.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2022/04]AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SK17.02.2021
SM17.02.2021
LU27.04.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2021/50]AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
MC17.02.2021
NL17.02.2021
PL17.02.2021
RO17.02.2021
RS17.02.2021
SE17.02.2021
SK17.02.2021
SM17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2021/49]AT17.02.2021
CZ17.02.2021
DK17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
NL17.02.2021
PL17.02.2021
RS17.02.2021
SE17.02.2021
SM17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2021/48]AT17.02.2021
CZ17.02.2021
EE17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
NL17.02.2021
PL17.02.2021
RS17.02.2021
SE17.02.2021
SM17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2021/46]AT17.02.2021
FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
NL17.02.2021
PL17.02.2021
RS17.02.2021
SE17.02.2021
SM17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2021/42]FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
NL17.02.2021
PL17.02.2021
RS17.02.2021
SE17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
IS17.06.2021
PT17.06.2021
Former [2021/39]FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
NL17.02.2021
PL17.02.2021
RS17.02.2021
SE17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2021/38]FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
NL17.02.2021
RS17.02.2021
SE17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2021/37]FI17.02.2021
HR17.02.2021
LT17.02.2021
LV17.02.2021
RS17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2021/36]FI17.02.2021
HR17.02.2021
LT17.02.2021
BG17.05.2021
NO17.05.2021
GR18.05.2021
PT17.06.2021
Former [2021/35]FI17.02.2021
HR17.02.2021
LT17.02.2021
NO17.05.2021
PT17.06.2021
Former [2021/33]FI17.02.2021
LT17.02.2021
NO17.05.2021
PT17.06.2021
Documents cited:Search[XD] WO2007046102  (ZINGER MENNI MENASHE et al.) [XD] 1-5 * abstract * * page 1, line 4 - line 8 * * page 5, line 26 - page 7, line 23 * * page 9, line 12 - line 17 * * claims 1-15 * * page 9, line 26 - line 28 * * page 15, line 5 - line 30 * * claims 1-258 *
 [A]   MACMILLAN F S ET AL: "THE ANTIPERSPIRANT ACTION OF TOPICALLY APPLIED ANTICHOLINERGICS", JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER, NL, vol. 43, 1 November 1964 (1964-11-01), pages 363 - 377, XP009089620, ISSN: 0022-202X, DOI: 10.1038/JID.1964.62 [A] 1-5 * abstract *

DOI:   http://dx.doi.org/10.1038/jid.1964.62
International search[XA] WO2010062930  (DRY PHARMA LLC et al.) [X] 1, 4, 5 * , page 6, 3rd paragraph; page 11, the last paragraph to page 12, 1st paragraph; example 16; claim 1 & US 2010/0137357 A1 *[A] 2, 3
 [YA] WO9528914  (HISAMITSU PHARMACEUTICAL CO et al.) [Y] 1, 2, 4, 5 * , example 6; page 13, 1st paragraph & US 5733900 A example 6; column 9, 2nd paragraph & EP 757910 A1 & DE 69528165 T2 & AU 2266995 A *[A] 3
 [YA]   DEL BOZ, J: "Systemic treatment ot hypernidrosis", ACTAS DERMO-SIFILIOGRAFICAS, vol. 106, no. 4, 6 April 2015 (2015-04-06), pages 271 - 277, XP029220272, ISSN: 0001-7310 [Y] 1, 2, 4, 5 * , page 274, right column, the last paragraph to page 275 right column, 2nd paragraph * [A] 3

DOI:   http://dx.doi.org/10.1016/j.adengl.2015.03.003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.